Publications

  1. Byeon SK, Madugundu AK, Garapati K, Ramarajan MG, Saraswat M, Kumar-M P, Hughes T, Shah R, Patnaik MM, Chia N, Ashrafzadeh-Kian S, Yao JD, Pritt BS, Cattaneo R, Salama ME, Zenka RM, Kipp BR, Grebe SKG, Singh RJ, Sadighi Akha AA, Algeciras-Schimnich A, Dasari S, Olson JE, Walsh JR, Venkatakrishnan AJ, Jenkinson G, O'Horo JC, Badley AD, Pandey A. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study. Lancet Digit Health. 2022 Sep; 4 (9):e632-e645 Epub 2022 July 11
    View PubMed
  2. Vanderboom PM, Renuse S, Maus AD, Madugundu AK, Kemp JV, Gurtner KM, Singh RJ, Grebe SK, Pandey A, Dasari S. Machine Learning-Based Fragment Selection Improves the Performance of Qualitative PRM Assays. J Proteome Res. 2022 Aug 5; 21 (8):2045-2054 Epub 2022 July 18
    View PubMed
  3. Mangalaparthi KK, Chavan S, Madugundu AK, Renuse S, Vanderboom PM, Maus AD, Kemp J, Kipp BR, Grebe SK, Singh RJ, Pandey A. Correction: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples. Clin Proteomics. 2022 May 4; 19 (1):11 Epub 2022 May 04
    View PubMed
  4. Genere N, Kaur RJ, Athimulam S, Thomas MA, Nippoldt T, Van Norman M, Singh R, Grebe S, Bancos I. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment. J Clin Endocrinol Metab. 2022 Feb 17; 107 (3):e1221-e1230
    View PubMed
  5. Maus A, Renuse S, Kemp J, Madugundu AK, Vanderboom PM, Blommel J, Jerde C, Dasari S, Kipp BR, Singh RJ, Grebe SK, Pandey A. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides. J Proteome Res. 2022 Jan 7; 21 (1):142-150 Epub 2021 Nov 15
    View PubMed
  6. Karon BS, Donato LJ, Bridgeman AR, Blommel JH, Kipp B, Maus A, Renuse S, Kemp J, Madugundu AK, Vanderboom PM, Chavan S, Dasari S, Singh RJ, Grebe SK, Pandey A. Analytical Sensitivity and Specificity of Four Point of Care Rapid Antigen Diagnostic Tests for SARS-CoV-2 Using Real-Time Quantitative PCR, Quantitative Droplet Digital PCR, and a Mass Spectrometric Antigen Assay as Comparator Methods. Clin Chem. 2021 Nov 1; 67 (11):1545-1553
    View PubMed
  7. Mangalaparthi KK, Chavan S, Madugundu AK, Renuse S, Vanderboom PM, Maus AD, Kemp J, Kipp BR, Grebe SK, Singh RJ, Pandey A. A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples. Clin Proteomics 2021 Oct 22; 18 (1):25
    View PubMed
  8. Maus AD, Kemp JV, Hoffmann TJ, Ramsay SL, Grebe SKG. Isotopic Distribution Calibration for Mass Spectrometry. Anal Chem. 2021 Sep 21; 93 (37):12532-12540 Epub 2021 Sept 07
    View PubMed
  9. Renuse S, Vanderboom PM, Maus AD, Kemp JV, Gurtner KM, Madugundu AK, Chavan S, Peterson JA, Madden BJ, Mangalaparthi KK, Mun DG, Singh S, Kipp BR, Dasari S, Singh RJ, Grebe SK, Pandey A. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens. EBioMedicine. 2021 Jul; 69:103465 Epub 2021 July 03
    View PubMed
  10. Wiltshire TD, Milosevic D, Jacob EK, Grebe SK, Dietz AB. Sensitive detection of integrated and free transcripts in chimeric antigen receptor T-cell manufactured cell products using droplet digital polymerase chain reaction. Cytotherapy. 2021 May; 23 (5):452-458 Epub 2021 Mar 11
    View PubMed
  11. Boggs ASP, Kilpatrick LE, Burdette CQ, Tevis DS, Fultz ZA, Nelson MA, Jarrett JM, Kemp JV, Singh RJ, Grebe SKG, Wise SA, Kassim BL, Long SE. Development of a pregnancy-specific reference material for thyroid biomarkers, vitamin D, and nutritional trace elements in serum. Clin Chem Lab Med. 2021 Mar 26; 59 (4):671-679 Epub 2020 Oct 26
    View PubMed
  12. Athimulam S, Grebe S, Bancos I. Steroid profiling in the diagnosis of mild and overt Cushing's syndrome. Best Pract Res Clin Endocrinol Metab. 2021 Jan; 35 (1):101488 Epub 2021 Feb 06
    View PubMed
  13. Stephens Z, Milosevic D, Kipp B, Grebe S, Iyer RK, Kocher JA. PB-Motif-A Method for Identifying Gene/Pseudogene Rearrangements With Long Reads: An Application to CYP21A2 Genotyping. Front Genet. 2021; 12:716586 Epub 2021 July 28
    View PubMed
  14. Grebe SKG. Commentary on Cryptogenic Cushing Syndrome Due to a White Lie. Clin Chem 2020 May 1; 66 (5):662-663
    View PubMed
  15. Kluge ML, Graber E, Foley K, Hansen LV, Sellers HL, Milosevic D, Cradic KW, Grebe SK. Monozygotic twins discordant for congenital adrenal hyperplasia due to mosaicism. Eur J Endocrinol. 2020 Feb; 182 (2):K7-K13
    View PubMed
  16. Maus A, Kemp J, Milosevic D, Renuse S, Pandey A, Singh RJ, Grebe SKG. Center of Mass Calculation in Combination with MS/MS Allows Robust Identification of Single Amino Acid Polymorphisms in Clinical Measurements of Insulin-Like Growth Factor-1. J Proteome Res. 2020 Jan 3; 19 (1):186-193 Epub 2019 Dec 09
    View PubMed
  17. Kaur RJ, Pichurin PN, Hines JM, Singh RJ, Grebe SK, Bancos I. Adrenal Cortical Carcinoma Associated With Lynch Syndrome: A Case Report and Review of Literature. J Endocr Soc. 2019 Apr 1; 3 (4):784-790 Epub 2019 Mar 05
    View PubMed
  18. Milosevic D, Mills JR, Campion MB, Vidal-Folch N, Voss JS, Halling KC, Highsmith WE, Liu MC, Kipp BR, Grebe SKG. Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing. Clin Chem. 2018 Dec; 64 (12):1732-1742 Epub 2018 Sept 20
    View PubMed
  19. Nasir H, Ali SI, Haque N, Grebe SK, Kirmani S. Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab. 2018 Sep; 23 (3):158-161 Epub 2018 Sept 28
    View PubMed
  20. Marlow LA, Rohl SD, Miller JL, Knauf JA, Fagin JA, Ryder M, Milosevic D, Netzel BC, Grebe SK, Reddi HV, Smallridge RC, Copland JA. Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts. J Clin Endocrinol Metab. 2018 Sep 1; 103 (9):3169-3182
    View PubMed
  21. Galior K, Grebe S, Singh R. Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Nutrients. 2018 Jul 24; 10 (8) Epub 2018 July 24
    View PubMed
  22. Galior K, Ketha H, Grebe S, Singh RJ. 10 years of 25-hydroxyvitamin-D testing by LC-MS/MS-trends in vitamin-D deficiency and sufficiency. Bone Rep. 2018 Jun; 8:268-273 Epub 2018 May 23
    View PubMed
  23. Oliveira JL, Coon LM, Frederick LA, Hein M, Swanson KC, Savedra ME, Porter TR, Patnaik MM, Tefferi A, Pardanani A, Grebe SK, Viswanatha DS, Hoyer JD. Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experience. Am J Hematol. 2018 May 23 [Epub ahead of print]
    View PubMed
  24. Grebe SKG, Algeciras-Schimnich A, American Thyroid Association's Laboratory Services Committee, American Association for Clinical Chemistry's Endocrine Division Steering Committee. Laboratory Services for Managing Thyroid Disease: Different and Common Viewpoints of American Thyroid Association Members and of Members of the Endocrine Division of the American Association for Clinical Chemistry. Thyroid 2017 Dec; 27 (12):1583-1585
    View PubMed
  25. Hines JM, Bancos I, Bancos C, Singh RD, Avula AV, Young WF, Grebe SK, Singh RJ. High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders. Clin Chem. 2017 Dec; 63 (12):1824-1835 Epub 2017 Aug 16
    View PubMed
  26. Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Endocr Pathol. 2017 Sep; 28 (3):253-268
    View PubMed
  27. Grebe SKG, Singh RJ. Clinical peptide and protein quantification by mass spectrometry (ms) Trac-Trends In Analytical Chemistry. 2016 Nov; 84:131-43.
  28. Juskewitch JE, Abraham RS, League SC, Jenkins SM, Smith CY, Enders FT, Grebe SK, Carey WA, Huskins WC. Monocyte HLA-DR expression and neutrophil CD64 expression as biomarkers of infection in critically ill neonates and infants. Pediatr Res. 2015 Dec; 78 (6):683-90 Epub 2015 Aug 31
    View PubMed
  29. Netzel BC, Grebe SK, Carranza Leon BG, Castro MR, Clark PM, Hoofnagle AN, Spencer CA, Turcu AF, Algeciras-Schimnich A. Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes. J Clin Endocrinol Metab. 2015 Aug; 100 (8):E1074-83 Epub 2015 June 16
    View PubMed
  30. Giovanella L, Feldt-Rasmussen U, Verburg FA, Grebe SK, Plebani M, Clark PM. Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges. Clin Chem Lab Med. 2015 Aug; 53(9):1301-14.
    View PubMed
  31. Ketha H, Singh RJ, Grebe SK, Bergstralh EJ, Rule AD, Lieske JC, Kumar R. Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers. PLoS One. 2015; 10 (9):e0137350 Epub 2015 Sept 02
    View PubMed
  32. Liu DM, Torchen LC, Sung Y, Paparodis R, Legro RS, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Hum Reprod. 2014 Dec; 29 (12):2764-72 Epub 2014 Oct 21
    View PubMed
  33. von Roemeling CA, Radisky DC, Marlow LA, Cooper SJ, Grebe SK, Anastasiadis PZ, Tun HW, Copland JA. Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. Cancer Res. 2014 Sep 1; 74 (17):4796-810 Epub 2014 June 24
    View PubMed
  34. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014 Jun; 99 (6):1915-42
    View PubMed
  35. Isham CR, Netzel BC, Bossou AR, Milosevic D, Cradic KW, Grebe SK, Bible KC. Development and characterization of a differentiated thyroid cancer cell line resistant to VEGFR-targeted kinase inhibitors. J Clin Endocrinol Metab. 2014 Jun; 99 (6):E936-43 Epub 2014 Mar 14
    View PubMed
  36. Ketha H, Kaur S, Grebe SK, Singh RJ. Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century. Curr Opin Endocrinol Diabetes Obes. 2014 Jun; 21(3):217-26.
    View PubMed
  37. Bancos I, Algeciras-Schimnich A, Grebe SK, Donato LJ, Nippoldt TB, Erickson D. Evaluation of Variables Influencing the Measurement of Insulin-like Growth Factor-1. Endocr Pract. 2014 May; 20 (5):421-6
    View PubMed
  38. Cradic KW, Murphy SJ, Drucker TM, Sikkink RA, Eberhardt NL, Neuhauser C, Vasmatzis G, Grebe SK. A simple method for gene phasing using mate pair sequencing. BMC Med Genet. 2014 Feb 6; 15:19 Epub 2014 Feb 06
    View PubMed
  39. Smallridge RC, Chindris AM, Asmann YW, Casler JD, Serie DJ, Reddi HV, Cradic KW, Rivera M, Grebe SK, Necela BM, Eberhardt NL, Carr JM, McIver B, Copland JA, Thompson EA. RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma. J Clin Endocrinol Metab. 2014 Feb; 99 (2):E338-47 Epub 2013 Dec 02
    View PubMed
  40. Netzel BC, Grebe SK. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer. Clin Chim Acta. 2013 Oct 21; 425:1-2 Epub 2013 July 04
    View PubMed
  41. Tolan NV, Vidal-Folch N, Algeciras-Schimnich A, Singh RJ, Grebe SK. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples. Clin Chim Acta. 2013 Sep 23; 424:216-21. Epub 2013 Jun 15.
    View PubMed
  42. Algeciras-Schimnich A, Bruns DE, Boyd JC, Bryant SC, La Fortune KA, Grebe SK. Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Clin Chem. 2013 Aug; 59 (8):1187-94 Epub 2013 Apr 16
    View PubMed
  43. Grebe SKG. Soluble thyroid tumor markers - old and new challenges and potential solutions. New Zealand Journal of Medical Laboratory Science. 2013; 67(3):76-87.
  44. Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, Tun HW, Colon-Otero G, Perez EA, Copland JA. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Cancer Ther. 2012 Oct; 11 (10):2105-15 Epub 2012 July 23
    View PubMed
  45. Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, Milosevic D, Porcher JC, Asmann YW, Smith DI, Kovtun IV, Ansell SM, Dogan A, Feldman AL. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood. 2012 Sep 13; 120 (11):2280-9 Epub 2012 Aug 01
    View PubMed
  46. Grebe SK, Kahaly GJ. Laboratory testing in hyperthyroidism. Am J Med. 2012 Sep; 125(9):S2.
    View PubMed
  47. Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK. Molecular testing in congenital adrenal hyperplasia due to 21alpha-hydroxylase deficiency in the era of newborn screening. Clin Genet. 2012 Jul; 82(1):64-70. Epub 2011 Jun 03.
    View PubMed
  48. Algeciras-Schimnich A, Lasho MA, Ness KM, Cheryk LA, Grebe SK. The Roche Elecsys and Siemens-Centaur thyroglobulin autoantibody assays show comparable clinical performance to the recently unavailable Beckman-Coulter access thyroglobulin autoantibody assay in identifying samples with potentially false-low Thyroid. 2011 Jul; 21(7):813-4.
    View PubMed
  49. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011 Jun; 57(6):833-40. Epub 2011 Apr 12.
    View PubMed
  50. Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA. Graves' disease: diagnostic and therapeutic challenges (multimedia activity). Am J Med. 2011 Jun; 124(6):S2-3.
    View PubMed
  51. Netzel BC, Cradic KW, Bro ET, Girtman AB, Cyr RC, Singh RJ, Grebe SK. Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3. Clin Chem. 2011 Mar; 57 (3):431-40 Epub 2011 Jan 18
    View PubMed
  52. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011 Mar; 57(3):411-20. Epub 2011 Jan 24.
    View PubMed
  53. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer. 2011 Feb; 18(1):97-111. Epub 2010 Dec 21.
    View PubMed
  54. Reddi HV, Madde P, Milosevic D, Hackbarth JS, Algeciras-Schimnich A, McIver B, Grebe SK, Eberhardt NL. The Putative PAX8/PPARgamma Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARgamma Activity. Genes Cancer. 2011 Jan; 2 (1):46-55
    View PubMed
  55. Hackbarth JS, Hoyne JB, Grebe SK, Singh RJ. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids. 2011 Jan; 76 (1-2):48-55
    View PubMed
  56. Grebe SKG, Singh RJ. LC-MS/MS in the clinical laboratory - Where to from here? Clinical Biochemist Reviews. 2011; 32:5-32.
  57. Marlow LA, D'Innocenzi J, Zhang Y, Rohl SD, Cooper SJ, Sebo T, Grant C, McIver B, Kasperbauer JL, Wadsworth JT, Casler JD, Kennedy PW, Highsmith WE, Clark O, Milosevic D, Netzel B, Cradic K, Arora S, Beaudry C, Grebe SK, Silverberg ML, Azorsa DO, Smallridge RC, Copland JA. Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target. J Clin Endocrinol Metab. 2010 Dec; 95 (12):5338-47 Epub 2010 Sept 01
    View PubMed
  58. Eberhardt NL, Grebe SK, McIver B, Reddi HV. The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer. Mol Cell Endocrinol. 2010 May 28; 321 (1):50-6 Epub 2009 Oct 31
    View PubMed
  59. Reddi HV, Madde P, Marlow LA, Copland JA, McIver B, Grebe SK, Eberhardt NL. Expression of the PAX8/PPARgamma Fusion Protein Is Associated with Decreased Neovascularization In Vivo: Impact on Tumorigenesis and Disease Prognosis. Genes Cancer. 2010 May; 1 (5):480-492
    View PubMed
  60. Milosevic D, Lundquist P, Cradic K, Vidal-Folch N, Huynh T, Pacak K, Grebe SK. Development and validation of a comprehensive mutation and deletion detection assay for SDHB, SDHC, and SDHD. Clin Biochem. 2010 May; 43 (7-8):700-4 Epub 2010 Feb 12
    View PubMed
  61. Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab. 2010 May; 95(5):2180-6. Epub 2010 Mar 12.
    View PubMed
  62. Algeciras-Schimnich A, Milosevic D, McIver B, Flynn H, Reddi HV, Eberhardt NL, Grebe SK. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. Clin Chem. 2010 Mar; 56 (3):391-8 Epub 2010 Jan 07
    View PubMed
  63. Kumar V, Barnidge DR, Chen LS, Twentyman JM, Cradic KW, Grebe SK, Singh RJ. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem. 2010 Feb; 56 (2):306-13 Epub 2009 Dec 10
    View PubMed
  64. Reddi HV, Madde P, Marlow LA, Copland JA, McIver B, Grebe SKG, Eberhardt NL. Expression of the PAX8/PPAR gamma fusion protein is associated with decreased neovascularization in vivo: Impact on tumorigenesis and disease prognosis. Genes and Cancer. 2010; 1(5):480-92.
  65. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Bhattacharya A, Lea R, Grebe SK. Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology. 2010; 42(6):524-33.
    View PubMed
  66. Eberhardt NL, Grebe SKG, McIver B, Reddi HV. The role of the PAX8/PPAR gamma fusion oncogene in the pathogenesis of follicular thyroid cancer. Mol Cell Endocrinol. 2010; 321(1):50-6.
  67. Cradic KW, Milosevic D, Rosenberg AM, Erickson LA, McIver B, Grebe SK. Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status. J Clin Endocrinol Metab. 2009 Dec; 94 (12):5001-9 Epub 2009 Oct 22
    View PubMed
  68. Saenger AK, Dalenberg DA, Bryant SC, Grebe SK, Jaffe AS. Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. Clin Chem. 2009 Oct; 55 (10):1869-75 Epub 2009 Aug 13
    View PubMed
  69. Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SK. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2009 Mar; 94 (3):861-8 Epub 2008 Dec 16
    View PubMed
  70. Grebe SKG. Diagnosis and management of thyroid carcinoma: A focus on serum thyroglobulin. Expert Review of Endocrinology and Metabolism. 2009; 4(1):25-43.
  71. Reddi HV, Madde P, Reichert-Eberhardt AJ, Galanis EC, Copland JA, McIver B, Grebe SK, Eberhardt NL. ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice. Cancer Gene Ther. 2008 Nov; 15 (11):750-7 Epub 2008 June 27
    View PubMed
  72. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol. 2008 Jun; 215(2):145-54.
    View PubMed
  73. Algeciras-Schimnich A, Preissner CM, Young WF Jr, Singh RJ, Grebe SK. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab. 2008 Jan; 93 (1):91-5 Epub 2007 Oct 16
    View PubMed
  74. Placzkowski KA, Reddi HV, Grebe SK, Eberhardt NL, McIver B. The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer. PPAR Res. 2008; 2008:672829 Epub 2008 Oct 29
    View PubMed
  75. Snozek CL, Chambers EP, Reading CC, Sebo TJ, Sistrunk JW, Singh RJ, Grebe SK. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab. 2007 Nov; 92: (11)4278-81.
    View PubMed
  76. Reddi HV, McIver B, Grebe SK, Eberhardt NL. The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis. Endocrinology. 2007 Mar; 148 (3):932-5 Epub 2006 Aug 31
    View PubMed
  77. Reddi HV, Algeciras-Schimnich A, McIver B, Eberhardt NL, Grebe SKG. Chromosomal rearrangements and the pathogenesis of differentiated thyroid cancer. Onc Rev. 2007; 1(2):81-90.
  78. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab. 2007 Jan; 92(1):82-7.
    View PubMed
  79. Copland JA, Marlow LA, Williams SF, Grebe SK, Gumz ML, Maples WJ, Silverman VE, Smallridge RC. Molecular diagnosis of a BRAF papillary thyroid carcinoma with multiple chromosome abnormalities and rare adrenal and hypothalamic metastases. Thyroid. 2006 Dec; 16(12):1293-302.
    View PubMed
  80. Babic N, Larson TS, Grebe SK, Turner ST, Kumar R, Singh RJ. Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. Clin Chem. 2006 Nov; 52 (11):2155-7
    View PubMed
  81. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006 Aug; 91 (8):3055-61 Epub 2006 May 23
    View PubMed
  82. Eastvold ML, Wallinder HW, Preissner CM, Singh RJ, Lowbeer C, Grebe SK. A two-center international evaluation of the Immulite 2000 automated serum gastrin assay. Clin Biochem. 2006 Apr; 39 (4):387-90 Epub 2006 Feb 07
    View PubMed
  83. Preissner CM, Dodge LA, O'Kane DJ, Singh RJ, Grebe SK. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem. 2005 Jan; 51 (1):208-10
    View PubMed
  84. Gomez EA, Ehresmann DD, Ledebuhr LK, Eastvold ML, Singh RJ, Klee GG, Grebe SK. Development and validation of an automated chemiluminometric immunoassay for human intrinsic factor antibodies in serum. Clin Chem. 2005 Jan; 51(1):232-5.
    View PubMed
  85. Sahin M, Allard BL, Yates M, Powell JG, Wang XL, Hay ID, Zhao Y, Goellner JR, Sebo TJ, Grebe SK, Eberhardt NL, McIver B. PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab. 2005 Jan; 90: (1)463-8.
    View PubMed
  86. Taylor RL, Grebe SK, Singh RJ. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem. 2004 Dec; 50 (12):2345-52 Epub 2004 Oct 14
    View PubMed
  87. Brown SA, Lipschitz AH, Kenkel JM, Sorokin E, Shepherd G, Grebe S, Oliver LK, Luby M, Rohrich RJ. Pharmacokinetics and safety of epinephrine use in liposuction. Plast Reconstr Surg. 2004 Sep 1; 114: (3)756-63.
    View PubMed
  88. McIver B, Grebe SK, Eberhardt NL. The PAX8/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep; 4 (3):221-34
    View PubMed
  89. Preissner CM, Reilly WM, Cyr RC, O'Kane DJ, Singh RJ, Grebe SK. Plastic versus glass tubes: effects on analytical performance of selected serum and plasma hormone assays. Clin Chem. 2004 Jul; 50 (7):1245-7
    View PubMed
  90. Cradic KW, Wells JE, Allen L, Kruckeberg KE, Singh RJ, Grebe SK. Substitution of 3'-phosphate cap with a carbon-based blocker reduces the possibility of fluorescence resonance energy transfer probe failure in real-time PCR assays. Clin Chem. 2004 Jun; 50 (6):1080-2
    View PubMed
  91. Powell JG, Wang XY, Allard BL, Sahin M, Wang XL, Hay ID, Hiddinga HJ, Deshpande SS, Kroll TG, Grebe SKG, Eberhardt NL, McIver B. The PAX8/PPARc fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARc inhibition. Oncogene. 2004 Apr 29; 23(20):3634-41.
    View PubMed
  92. Gregory Powell J, Wang X, Allard BL, Sahin M, Wang XL, Hay ID, Hiddinga HJ, Deshpande SS, Kroll TG, Grebe SK, Eberhardt NL, McIver B. The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition. Oncogene. 2004 Apr 29; 23 (20):3634-41
    View PubMed
  93. Nelson RE, Grebe SK, OKane DJ, OKane DJ, Singh RJ. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem. 2004 Feb; 50 (2):373-84 Epub 2003 Dec 04
    View PubMed
  94. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC. Effects of reducing the upper limit of normal TSH values. JAMA: Journal of the American Medical Association. 2003 Dec 24; 290(24):3195-6.
    View PubMed
  95. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab. 2003 Jul; 88 (7):3069-74
    View PubMed
  96. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SKG. Thyroid gland clonality revisited: The embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab. 2003 Jul; 88(7):3284-91.
    View PubMed
  97. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SKG. Optimising restriction enzyme cleavage of DNA derived from archival histopathological samples: an improved HUMARA assay. Pathology (Phila). 2003 Jan; 35: (1)70-4.
    View PubMed
  98. Farrand K, Delahunt B, Wang XL, McIver B, Hay ID, Goellner JR, Eberhardt NL, Grebe SKG. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. J Clin Endocrinol Metab. 2002 Oct; 87(10):4715-21.
    View PubMed
  99. Farrand K, Jovanovic L, Delahunt B, McIver B, Hay ID, Eberhardt NL, Grebe SKG. Loss of heterozygosity studies revisited - Prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn. 2002 Aug; 4(3):150-8.
    View PubMed
  100. Velickovic M, Delahunt B, McIver B, Grebe SKG. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis. Mod Pathol. 2002 May; 15(5):479-85.
    View PubMed
  101. Delahunt B, Velickovic M, Grebe SK. Evolving classification of renal cell neoplasia. Expert Rev Anticancer Ther. 2001 Dec; 1(4):576-84.
  102. Barber R, Delahunt B, Grebe SK, Davis PF, Thornton A, Slim GC. Oral shark cartilage does not abolish carcinogenesis but delays tumor progression in a murine model. Anticancer Res. 2001 Mar-Apr; 21(2A):1065-9.
    View PubMed
  103. McIver B, Grebe SK, Wang L, Hay ID, Yokomizo A, Liu W, Goellner JR, Grant CS, Smith DI, Eberhardt NL. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. Clin Endocrinol (Oxf). 2000 Jun; 52(6):749-57.
    View PubMed
  104. McIver B, Grebe SKG, Wang L, Hay ID, Yokomizo Yokomizo, Liu W, Goellner JR, Grant CS, Smith DI, Eberhardt NL. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. Clin Endocrinol (Oxf). 2000 Jun; 52 (6):749-757
    View PubMed
  105. Velickovic M, Delahunt B, Grebe SKG. Loss of heterozygosity at 3p14. 2 in clear cell renal cell carcinoma is an early event and highly localized to the FHIT gene locus Cancer Research. 1999; 59:1323-6.
  106. Jordan V, Grebe SKG, Cooke RR, Ford HC, Larsen PD, Stone PR, Salmond CE. Acidic isoforms of chorionic gonadotrophin in European and Samoan women are associated with hyperemesis gravidarum and may be thyrotrophic. Clinical Endocrinology. 1999; 50:619-27.
    View PubMed
  107. Velickovic ZM, Velickovic MB, Grebe SKG. Increasing sample thorughput on a standard 36 lane PE-ABI 377(TM) automated DNA sequencer to 48 or 64 samples per run. BioTechniques. 1999; 27:652-4.
    View PubMed
  108. Delahunt B, Eble JN, Nacey JN, Grebe SKG. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression. Anticancer Research. 1999; 19:4279-84.
    View PubMed
  109. Grebe SKG, Feek CM, Ford HC, Fagerstroem JN, Cordwell DP, Delahunt JW, Toomath R. A randomised trial of short term treatment of Graves' disease with high dose carbimazole plus thyroxine versus titration dose carbimazole. Clinical Endocrinology. 1998; 48:585-92.
    View PubMed
  110. Grebe SK, McIver B, Hay ID, Wu PS, Maciel LM, Drabkin HA, Goellner JR, Grant CS, Jenkins RB, Eberhardt NL. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab. 1997 Nov; 82: (11)3684-91.
    View PubMed
  111. Grebe SK, Cooke RR, Ford HC, Fagerstrom JN, Cordwell DP, Lever NA, Purdie GL, Feek CM. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab. 1997 Mar; 82(3):870-5.
    View PubMed
  112. Grebe SK, Hay ID. Follicular cell-derived thyroid carcinomas. Cancer Treat Res. 1997; 89:91-140
    View PubMed
  113. Grebe SK, Hay ID. The role of surgery in the management of differentiated thyroid cancer. J Endocrinol Invest. 1997 Jan; 20 (1):32-5
    View PubMed
  114. Grebe SKG, Feek CM, Durham JA, Kljakovic M, Cooke RR. Inhaled beclomethasone diproprionate suppresses the hypothalamic-pituitary-adrenal axis in a dose dependent manner. Clinical Endocrinology. 1997; 47:297-304.
    View PubMed
  115. Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996 Jan; 5 (1):43-63
    View PubMed
  116. Grebe SF, Sattler EL, Rinkenberger C, Bodenmüller D, Grebe SKG, Müller KD, Fängewich G-L, Heckers H, Steckenmesser R. Studies of Se-75 labeled bile acid analogue absorption in different forms of gastrointestinal diseases using a whole body counter. Nuklear Medizin. 1996; 35:86-93.
  117. Grebe SK, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am. 1995 Dec; 24 (4):761-801
    View PubMed
  118. Grebe SKG, Delahunt JW, Feek CM, Purdie G, Porter DJ. Lack of evidence for pituitary thyrotroph downregulation after 1 week of oral TRH and Metoclopramide under conditions of constant peripheral thyroid hormone levels. European Journal of Endocrinology. 1995; 132:331-7.
    View PubMed
  119. Grebe SKG, Smith RBW. Clinical audit and standardised follow up improve the quality of documentation in diabetes care. New Zealand Medical Journal. 1995; 108:339-42.
    View PubMed
  120. Grebe SF, Grebe MT, Boensel K, Mueller KD, Grebe SKG, Bahavar H, Schlepper M, Hemplemann G. Change of thyroid parameters in cardiac disease. Klinisches Labor. 1995; 41:677-85.
  121. Grebe SKG, Hay ID. Management of well-differentiated thyroid cancer. Postgraduate Doctor Middle East. 1995; 18:326-31.
  122. Grebe SKG, Hay ID. Management of differentiated thyroid cancer. Current Opinion in Endocrinology and Diabetes. 1995; 2:449-54.
  123. Grebe SKG, Adams J, Feek CM. Systemic sensitization to ethanol by transdermal estrogen patches. Archives of Dermatology. 1993; 129:379-280.
    View PubMed
  124. Grebe SKG, Delahunt JW, Feek CM. Treatment of extensively invasive giant prolactinomas with bromocriptine. New Zealand Medical Journal. 1992; 105:129-31.
    View PubMed
  125. Hill RW, Grebe SKG, Dady PJ. Hyperprolactinämie bei malignen Lymphomen. Deutsche Medizinische Wochenschrift. 1991; 117:198.
  126. Grebe SKG, Müller H. Der TSH-Spiegel bei der Hyperthyreose unter antithyroidaler Medikation. Schilddruese 1989 CR Pickardt, P Pfannenstiel, B Weinheimer, Editors. 1987:215-6.
  127. Grebe SKG, Müller H, Grebe SF, Stute I, Kovacs G, Schirmer W, Fängewisch G-L, Hoogendam BW. Differenzierungsgrößen bei 6 hypersensitiven TSH-Testen. Schilddruese 1986 P Pfannenstiel, D Emrich, B Weinheimer, Editors. 1985:100-2.
  128. Grebe SKG, Müller H. Einfluß von unterschiedlichen Levothyroxinedosen auf den mit einem hypersensitiven TSH-Test gemessenen TSH-Blutspiegel. Schilddrüse 198618-114 P Pfannenstiel, D Emrich, B Weinheimer, Editors. 1985.